Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Medicine Maker 2021 Power List has been published – celebrating the great minds working to bring patients new therapeutic products.
AAM calls for policies in the US that encourage greater use of biosimilars.
How can pharma use synthetic data to enhance clinical trials?
New guidance on the use of whey and lactose-derived products in pharmaceuticals.
How has COVID-19 affected the pharma industry and medicine makers across the world?
Fake COVID-19 treatments and vaccines are abound – but the FDA is on the case.
Mexico’s Customs and Armed Forces have seized a fake batch of the Sputnik V COVID-19 vaccine.
Kristen Hege, CAR T pioneer and adventurer, tells the story of her "misadventure" in the snowy High Sierras of Northern California.
Industry collaboration can only result in better treatments for lung cancer.
Craig Burton from the AAM says patients must be able to access generics and biosimilars.
How can the FDA tackle the inspection backlog?
We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.
Sputnik V (finally and definitely) starts rolling review with the EMA.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.